The First Cholesterol Pill in the PCSK9 Class Reaches Pharmacy Shelves at 315 Dollars a Month

The first oral PCSK9 inhibitor has reached US pharmacies at a $315 monthly list price. Here is what patients should ask before switching.

Have A Referral?